Earnings · China A-shares
Honz Pharmaceutical Co., Ltd. Class A (300086) earnings
Honz Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-25: net profit +21.55% year on year, +14.15% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -3.63% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-25
- Period end
- 2026-09-30
- Net profit YoY
- +21.55%
- Excl. one-offs YoY
- +14.15%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +0.00% | — |
| 3 days | -3.63% | — |
| 7 days | -4.84% | — |
| 14 days | -2.02% | — |
Report history
Over the last 8 reports, net profit grew year on year in 5 of them. The stock rose in the 3 trading days after 4 of 6 reports (average +3.93%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-26 | -¥75.79M | +21.55% | +14.15% | -39.99% | -0.17 | -8.79% | -3.63% | — | — |
| 2026 interim report | 2026-08-27 | -¥32.77M | +39.41% | +26.03% | -37.67% | -0.07 | -3.71% | -2.08% | -24.18% | -15.25% |
| 2026 Q1 report | 2026-04-29 | -¥11.75M | -21.24% | -11.05% | -14.09% | -0.03 | -1.31% | +8.35% | -10.65% | -11.59% |
| 2025 annual report | 2026-04-29 | -¥230.14M | -6.82% | +4.40% | -0.72% | -0.51 | -22.95% | +8.35% | -10.65% | -11.59% |
| 2025 Q3 report | 2025-10-27 | -¥96.61M | +21.28% | +30.24% | -10.29% | -0.21 | -8.85% | +11.93% | +53.95% | +54.18% |
| 2025 interim report | 2025-08-28 | -¥54.08M | +46.38% | +46.68% | +5.56% | -0.12 | -4.86% | +0.89% | +13.24% | +7.74% |
| 2025 Q1 report | 2025-04-29 | -¥9.69M | +79.16% | +76.99% | +7.33% | -0.02 | -0.85% | +8.13% | +18.06% | +15.48% |
| 2024 annual report | 2025-04-29 | -¥215.45M | -1975.20% | — | -31.88% | -0.48 | -17.75% | +8.13% | +18.06% | +15.48% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.